Allergy Therapeutics (AGY)

 

Latest News

Broker Forecast - finnCap issues a broker note on Allergy Therapeutics PLC

finnCap today reaffirms its buy investment rating on Allergy Therapeutics PLC (LON:AGY) and raised its price target to ...

Allergy Therapeutics ahead of forecasts

Allergy Therapeutics expects revenues for the year ended 30 June to be ahead of market forecasts at 64.1m (2016: 48.5m). A ...

Trading Update

RNS Number: 3133L Allergy Therapeutics PLC 18 July 2017 Allergy Therapeutics plc ("Allergy Therapeutics" or the "Group") Trading Update 15% constant currency revenue growth Double-digit compound annual revenue growth over the past 18 years 18 July 2017 Allergy Therapeutics plc (AIM:AGY), the fully integrated specialty pharmaceutical group specialising in...

Publication of adjuvant studies in journals

RNS Number: 2501K Allergy Therapeutics PLC 06 July 2017 Al l e r g y Th e r a p e u ti cs p l c (" A l l e r gy T he r a peu t i cs" or t he " Group " ) Two studies of adjuvants in malaria and influenza vaccines published in peer-reviewed journals ~ Publications demonstrate the potential of Allergy Therapeutics' novel adjuvant systems in infectious diseases , further bro...

All News

DateHeadlineSource
18-07-17Broker Forecast - finnCap issues a broker note on Allergy Therapeutics PLCStockMarketWire
18-07-17Allergy Therapeutics ahead of forecasts StockMarketWire
18-07-17Trading UpdateRNS
06-07-17Publication of adjuvant studies in journalsRNS
27-06-17Investor and analyst site visitsRNS
19-06-17Allergy Therapeutics hosts satellite symposium at EAACIStockMarketWire
19-06-17Satellite Symposium at EAACI 2017RNS
06-06-17Directorate changesRNS
02-06-17Holding(s) in CompanyRNS
13-04-17Issue of EquityRNS
05-04-17Hardman Research: Development across portfolioRNS
04-04-17Broker Forecast - Numis issues a broker note on Allergy Therapeutics PLCStockMarketWire
29-03-17Interim Results for six months ended 31 Dec 2016RNS
16-03-17Allergy Therapeutics recruits first patient in birch pollen trial StockMarketWire
16-03-17First Patient in Pivotal Phase III Birch StudyRNS
09-03-17Notice of Interim ResultsRNS
14-02-17Broker Forecast - Stifel issues a broker note on Allergy Therapeutics PLCStockMarketWire
14-02-17Allergy Therapeutics vaccine gains CTA spprovalStockMarketWire
14-02-17House Dust Mite Allergy Vaccine Gains CTA ApprovalRNS
08-02-17Directorate ChangeRNS
01-02-17Allergy Therapeutics positive data in peanut allergy vaccineStockMarketWire
01-02-17Positive Efficacy & Safety Data in Peanut VaccineRNS
20-01-17Hardman Research: Investment driving market shareRNS
19-01-17Broker Forecast - finnCap issues a broker note on Allergy Therapeutics PLCStockMarketWire
19-01-17Allergy Therapeutics revenues up StockMarketWire
19-01-17Trading UpdateRNS
09-01-17Top 10 small-cap share tips for 2017Interactive Investor
06-01-17Broker Forecast - finnCap issues a broker note on Allergy Therapeutics PLCStockMarketWire
30-12-16Grant of AwardsRNS
25-11-16Allergy Therapeutics resolutions passed at AGMStockMarketWire
24-11-16Result of AGMRNS
02-11-16Allergy Therapeutics granted EU patent StockMarketWire
02-11-16EU Patent Office grants patent for MCTRNS
27-10-16Issue of equity in respect of exercise of optionsRNS
24-10-16Annual Report and AccountsRNS
14-10-16Share of the week: Tipped to double againInteractive Investor
10-10-16New data from novel adjuvant systemRNS
03-10-16Issue of equity in respect of exercise of optionsRNS
29-09-16Director Deals - Allergy Therapeutics PLC (AGY)StockMarketWire
29-09-16Director/PDMR ShareholdingRNS

RSS feeds

  • Editorial news feed for LSE:AGY Editorial
  • Regulatory news feed for LSE:AGY Regulatory